tiprankstipranks
Trending News
More News >
Medtronic (MDT)
NYSE:MDT
US Market
Advertisement

Medtronic (MDT) Earnings Dates, Call Summary & Reports

Compare
6,332 Followers

Earnings Data

Report Date
Feb 17, 2026
Before Open (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
1.34
Last Year’s EPS
1.39
Same Quarter Last Year
Moderate Buy
Based on 19 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Nov 18, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected a positive outlook with strong quarterly performance, successful launches, and raised guidance. However, challenges remain with declining cryo revenue and tariff impacts.
Company Guidance
In the recent earnings call, Medtronic provided a comprehensive overview of its fiscal 2026 second-quarter performance, along with its updated guidance for the remainder of the fiscal year. The company reported second-quarter revenue of $9 billion, reflecting a 6.6% increase on a reported basis and 5.5% on an organic basis, surpassing expectations. Key growth drivers included a 71% increase in cardiac ablation revenues, primarily fueled by the PFA franchise, which saw over 300% growth in the U.S. and international markets. Adjusted EPS rose by 8% to $1.36, exceeding the midpoint of guidance by $0.05. Medtronic raised its full-year revenue growth guidance to 5.5%, a 50-basis-point increase from previous estimates, and anticipates high single-digit EPS growth in fiscal year 2027. The company is also investing significantly in R&D, aiming to bring it to 10% of revenue over time, while leveraging SG&A to enhance margins. Strategic growth areas include expansions in hypertension and incontinence markets with Simplicity and AltaViva, respectively, as well as advancements in robotics with Hugo. Despite the anticipated impact of tariffs, Medtronic remains focused on accelerating top-line growth and margin improvement, leveraging a robust pipeline and strategic investments in key technology areas.
Strong Second Quarter Performance
Medtronic's revenue and EPS exceeded expectations, driven by strong performance across various segments. The company raised its revenue growth and EPS guidance for the full year.
Cardiac Ablations Business Growth
The cardiac ablations business grew 71%, with PFA franchise growing over 300% in the U.S. and international markets. This growth is attributed to the Ferra mapping system and Sphere nine dual energy catheter.
Launch of Innovative Technologies
Successful launches of Simplicity for hypertension, HUGO and soft tissue robotics, and AltaViva for incontinence are expected to drive future growth.
Revenue and Geographic Growth
Second quarter revenue was $9 billion, growing 6.6% reported and 5.5% organic. Growth was balanced across geographies, with double-digit growth in Japan and mid-single-digit growth in the U.S., Western Europe, and China.
Diabetes Business Progress
The diabetes business saw high single-digit growth, with international markets growing 11%. New sensor launches are driving pent-up demand and orders.

Medtronic (MDT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MDT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 17, 2026
2026 (Q3)
1.34 / -
1.39
Nov 18, 2025
2026 (Q2)
1.31 / 1.36
1.267.94% (+0.10)
Aug 19, 2025
2026 (Q1)
1.23 / 1.26
1.232.44% (+0.03)
May 21, 2025
2025 (Q4)
1.58 / 1.62
1.4610.96% (+0.16)
Feb 18, 2025
2025 (Q3)
1.36 / 1.39
1.36.92% (+0.09)
Nov 19, 2024
2025 (Q2)
1.25 / 1.26
1.250.80% (+0.01)
Aug 20, 2024
2025 (Q1)
1.20 / 1.23
1.22.50% (+0.03)
May 23, 2024
2024 (Q4)
1.45 / 1.46
1.57-7.01% (-0.11)
Feb 20, 2024
2024 (Q3)
1.26 / 1.30
1.30.00% (0.00)
Nov 21, 2023
2024 (Q2)
1.18 / 1.25
1.3-3.85% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MDT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 18, 2025
$96.28$100.80+4.69%
Aug 19, 2025
$92.11$89.22-3.14%
May 21, 2025
$85.01$83.08-2.27%
Feb 18, 2025
$90.63$84.05-7.26%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medtronic (MDT) report earnings?
Medtronic (MDT) is schdueled to report earning on Feb 17, 2026, Before Open (Confirmed).
    What is Medtronic (MDT) earnings time?
    Medtronic (MDT) earnings time is at Feb 17, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MDT EPS forecast?
          MDT EPS forecast for the fiscal quarter 2026 (Q3) is 1.34.

            Medtronic (MDT) Earnings News

            MDT Earnings: Medtronic Stock Slips Despite Earnings Beat
            Premium
            Market News
            MDT Earnings: Medtronic Stock Slips Despite Earnings Beat
            7M ago
            MDT Earnings: Medtronic Diabetes and Heart Devices Drive Beat
            Premium
            Market News
            MDT Earnings: Medtronic Diabetes and Heart Devices Drive Beat
            10M ago
            MDT Earnings: Medtronic Beats Q2 Expectations, Boosts FY25 Guidance
            Premium
            Market News
            MDT Earnings: Medtronic Beats Q2 Expectations, Boosts FY25 Guidance
            1y ago
            MDT Earnings: Medtronic Boosts FY25 Outlook on Strong Q1 Results
            Premium
            Market News
            MDT Earnings: Medtronic Boosts FY25 Outlook on Strong Q1 Results
            1y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis